Technical Analysis for ACST - Acasti Pharma, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
1.34 | 3.08% | 0.04 |
ACST closed up 3.08 percent on Monday, August 21, 2017, on 2.01 times normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
Trend Table & Recent Alerts
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| See historical ACST trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Aug 21 | Crossed Above 50 DMA | Bullish | 0.00% |
| Aug 21 | 200 DMA Support | Bullish | 0.00% |
| Aug 21 | MACD Bullish Signal Line Cross | Bullish | 0.00% |
| Aug 18 | Fell Below 50 DMA | Bearish | 3.08% |
| Aug 18 | 200 DMA Support | Bullish | 3.08% |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio.
Profile
- Earnings date: 2017-08-14
- Sector: Healthcare
- Industry: Pharmaceuticals
Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of new therapies for abnormalities in blood lipids, and the treatment and prevention of cardiovascular disorders. The company offers Onemia, a medical food that is used in the dietary management of illnesses associated with omega-3 phospholipids deficiency related to cardiometabolic disorders. Its product development pipeline includes CaPre, a drug product candidate that is in Phase II clinical trial for the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada. Acasti Pharma Inc. is a subsidiary of Neptune Technologies & Bioressources Inc.
Is ACST a Buy, Sell or Hold?
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
Recent News
See more ACST news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 3.09 |
| 52 Week Low | 1.11 |
| Average Volume | 29,622 |
| 200-Day Moving Average | 1.2948 |
| 50-Day Moving Average | 1.3021 |
| 20-Day Moving Average | 1.307 |
| 10-Day Moving Average | 1.307 |
| Average True Range | 0.0753 |
| ADX | 42.74 |
| +DI | 16.19 |
| -DI: | 7.62 |
| Chandelier Exit (Long, 3 ATRs) | 1.2241 |
| Chandelier Exit (Short, 3 ATRs) | 1.4659 |
| Upper Bollinger Band | 1.3552 |
| Lower Bollinger Band | 1.2588 |
| Percent B (%b) | 0.84 |
| Bandwidth | 0.073757 |
| MACD Line | 0.0039 |
| MACD Signal Line | 0.0021 |
| MACD Histogram | 0.0018 |
